The striking association between PD-L1 expression in cancer cells and a high number of intratumoral CD8+ cytotoxic T-lymphocytes may suggest that PD-L1 overexpression is driven by a lymphocyte-rich microenvironment and constitutes one of the mechanisms allowing for immune evasion and further progression of highly immunogenic RCCs. The gene discussed is CD8A; the disease is cancer.